The nation of Zimbabwe has rejected a significant American healthcare agreement valued at $367m (272 million pounds) over five years due to Washington's demand for sensitive information.
This rejection came to light following a official document dated December was leaked, revealing that Head of State Emmerson Mnangagwa deemed the agreement was "skewed".
An official spokesperson has since stated that the United States was seeking genetic material for scientific study and profit but was unwilling to guarantee the benefits from any future vaccines.
"We will now turn to the challenging and unfortunate task of winding down our health assistance in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.
The US Embassy said the United States had donated more than $1.9bn as health assistance to Zimbabwe over the last twenty years.
A physicians' group in Zimbabwe has urged more dialogue to find a deal agreeable to both sides so the nation's vital HIV programme can be sustained.
Broader Context
This rejection follows a comparable case in neighbouring Kenya, where a court blocked a similar deal with the US after concerns were raised about the safety of citizens' medical information.
Since returning to the presidency last year, US President Donald Trump has slashed foreign aid and closed the key foreign aid agency.
USAID had overseen aid for the American government, but Trump claimed its spending was "wasteful" and his government was pursuing government-to-government agreements to boost transparency and accountability.
As per reports, Sixteen African countries have to date signed these new agreements, representing more than $18.3bn in committed funds.
Specifics of the Rejected Agreement
This assistance for Zimbabwe would have supported "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"It is our view this collaboration might have yielded extraordinary benefits for the people of Zimbabwe, especially the 1.2 million men, women and children currently receiving HIV treatment via US-supported programmes," the Ambassador added.
However, government spokesperson Nick Mangwana said the proposed deal was "asymmetrical".
"Zimbabwe was being asked to surrender its biological resources and data over an extended period, with no equivalent promise of benefiting from any medical innovations – like vaccines, diagnostics, or treatments – that might result from that provided information," he stated.
"Put simply, our nation would supply the basic resources for medical research with no certainty that the final treatments would be available to our people should a new pandemic emerge."
National Interest and Global Health
He also said that the US's withdrawal from the World Health Organization (WHO) and its push of one-on-one health agreements were undermining structures already set up via the global organization.
Mangwana cited its Pandemic Benefit-Sharing scheme designed to manage future global health emergencies.
"This system is designed to ensure that when a nation provides its samples, the resulting advantages – such as vaccines and treatments – are shared equitably, not commercialised exclusively by those with the resources to develop them."
These objections regarding the US deal "should not be misconstrued as hostility towards the US," Mangwana stressed.
"We encourage ongoing dialogue with our American counterparts on how future collaboration might be structured in a way that respects the sovereignty and interests of both nations."
Medical Community Response
A leading public health body stated it acknowledged the government's concerns, but recommended that talks should continue given that a large portion of the nation's Aids initiatives depended on international support.
"Where specific concerns exist, such as those involving data governance or implementation frameworks, these can frequently be resolved via technical clarification and mutually agreed protections," the group said.
This impasse underscores the complex debate between accepting vital foreign assistance and safeguarding local interests in an ever more data-driven world.